top of page

Accelerating vaccine development for the fight against COVID-19

Updated: May 26, 2021

“Rapid progress towards the development of potent vaccines can only happen through concerted and coordinated efforts around Europe and the world – and TRANSVAC2 is well positioned to facilitate such efforts.”

Learn how TRANSVAC2 is supporting the Present and transforming the Future of European vaccine R&D landscape not only by answering pressing healthcare challenges as the COVID-19 pandemic, but also in positioning Europe as a global leader in vaccine R&D, in the latest EU Science, Research and Innovation success story.

TRANSVAC2 Success Story_200709
Download PDF • 826KB


bottom of page